Skip to content

The effect of time-restricted eating combining oral nutritional supplementation on bodyweight loss in patients with obesity

The effect of time-restricted eating combining oral nutritional supplementation on bodyweight loss in patients with obesity: a pilot study in a pre-post design

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300070411
Enrollment
Unknown
Registered
2023-04-11
Start date
2023-04-15
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Interventions

intervention group:8-hour time-restricted feeding and oral nutritional supplement

Sponsors

Medical College of Wuhan University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Eating time window >=12 hours. 2. BMI >=23.9 kg/m^2 (weight (kg)/ height ^2 (m)). 3. Aged 30-65 years. 4. Sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Weight change >5kg in the past three months. 2. Pregnancy or breastfeeding. 3. Taking part in a weight loss or weight management program. 4. Have a history of weight control surgery or a special diet for other reasons. 5. Patients with diabetes who are receiving oral hypoglycemic drugs or insulin therapy. 6. Depression Screening Scale (PHQ-9) score <=10. 7. Have severe metabolic disease or major cardiovascular, kidney, heart, liver, lung or nervous system disease (hypoglycemia, diabetes, thyroid disease, stroke, kidney failure, chronic gastroenteritis, coronary heart disease, malignant tumor, myocardial infarction, chronic respiratory failure, blindness, deafness and paralysis, organ transplantation, coronary artery bypass, heart failure, dementia, Parkinson's disease, drug-induced fatty liver disease, viral hepatitis, autoimmune or cholestatic liver disease, Wilson's disease, hemochromatosis, alpha-1 antitrypsin deficiency). 8. Internship or abroad plan in the next 3 months, continuous intervention and follow-up cannot be guaranteed.

Design outcomes

Primary

MeasureTime frame
blood glucose;blood lipids;

Secondary

MeasureTime frame
sleep quality;blood pressure;liver function;weight;body composition;

Countries

China

Contacts

Public ContactRong Shuang

Wuhan University of Science and Technology

rongshuangwhu@yeah.net+86 185 7172 7264

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026